Successful treatment for West syndrome with severe combined immunodeficiency

Brain and Development

Volumn 37, Issue 1, 2015, Pages 140-144

  Motobayashi, Mitsuo ^a   Inaba, Yuji ^a   Fukuyama, Tetsuhiro ^b   Kurata, Takashi ^a   Niimi, Taemi ^a   Saito, Shoji ^a   Shiba, Naoko ^a   Nishimura, Takafumi ^a   Shigemura, Tomonari ^a   Nakazawa, Yozo ^a   Kobayashi, Norimoto ^a   Sakashita, Kazuo ^a   Agematsu, Kazunaga ^c   Ichikawa, Motoki ^a   Koike, Kenichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGANO CHILDREN'S HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD4 8; Hematopoietic stem cell transplantation; Intravenous injection of immunoglobulin; Severe combined immunodeficiency syndrome; West syndrome

Indexed keywords

FLUDARABINE PHOSPHATE; IMMUNOGLOBULIN; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; PYRIDOXINE; TACROLIMUS; THYMOCYTE ANTIBODY; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT; FRUCTOSE; IL2RG PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR GAMMA;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HYPSARRHYTHMIA; INFANT; INFANTILE SPASM; MALE; MISSENSE MUTATION; OUTCOME ASSESSMENT; SUBSTITUTION THERAPY; WEST SYNDROME; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; ANALOGS AND DERIVATIVES; B LYMPHOCYTE; COMPLICATION; DRUG EFFECTS; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; NEWBORN; PRESCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; SPASMS, INFANTILE; T LYMPHOCYTE;

ANTICONVULSANTS; B-LYMPHOCYTES; CHILD, PRESCHOOL; FRUCTOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; MALE; MUTATION, MISSENSE; SEVERE COMBINED IMMUNODEFICIENCY; SPASMS, INFANTILE; T-LYMPHOCYTES;

EID: 84919462120     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.01.012     Document Type: Article

References (13)

1. Kato M. A new paradigm for West syndrome based on molecular and cell biology. Epilepsy Res 2006, 70(Suppl. 1):S87-S95.
2. Ariizumi M., Baba K., Hibio S., Shiihara H., Michihiro N., Ogawa K., et al. Immunoglobulin therapy in the West syndrome. Brain Dev 1987, 9:422-425.
3. Ariizumi M., Baba K., Shiihara H., Ogawa K., Hibio S., Suzuki Y., et al. High dose gammaglobulin for intractable childhood epilepsy. Lancet 1983, 2:162-163.
4. Sugiura C., Maegaki Y., Kure H., Inoue T., Ohno K. Spontaneous remission of infantile spasms and hypsarrhythmia following acute infection with high-grade fever. Epilepsy Res 2007, 77:102-107.
5. Tsuji T., Okumura A., Ozawa H., Ito M., Watanabe K. Current treatment of West syndrome in Japan. J Child Neurol 2007, 22:560-564.
6. Hattori H. Spontaneous remission of spasms in West syndrome - implications of viral infection. Brain Dev 2001, 23:705-707.
7. Yamamoto H., Yamano T., Niijima S., Kohyama J., Yamanouchi H. Spontaneous improvement of intractable epileptic seizures following acute viral infections. Brain Dev 2004, 26:377-379.
8. Fischer A., Le Deist F., Hacein-Bey-Abina S., Andre-Schmutz I., Basile Gde S., de Villartay J.P., et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev 2005, 203:98-109.
9. Cheng S., Maeda T., Yamagata Z., Tomiwa K., Yamakawa N. Comparison of factors contributing to developmental attainment of children between 9 and 18 months. J Epidemiol 2010, 20(Suppl. 2):S452-S458.
10. Montelli T.C., Soares A.M., Peracoli M.T. Immunologic aspects of West syndrome and evidence of plasma inhibitory effects on T cell function. Arq Neuropsiquiatr 2003, 61:731-737.
11. Shiihara T., Miyashita M., Yoshizumi M., Watanabe M., Yamada Y., Kato M. Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Dev 2010, 32:695-702.
12. Riikonen R. Infantile spasms: infectious disorders. Neuropediatrics 1993, 24:274-280.
13. Fay J.W., Wingard J.R., Antin J.H., Collins R.H., Pineiro L.A., Blazar B.R., et al. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. Blood 1996, 87:3514-3519.